Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

News Briefs: CMS Sunshine Rule User Guide; Bard Acquisition; Sapien Japan Reimbursement

This article was originally published in The Gray Sheet

Executive Summary

CMS releases user guide and manual for companies to comply with the Physician Payments Sunshine Act rule provisions. CR Bard acquires Medafor to add to its Davol surgical specialties unit. More news.

You may also be interested in...



People Briefs: New CEO At DFINE; CMS Departure; FDA Seeks CIO

DFINE taps new president and CEO. CMS Program Integrity chief Peter Budetti steps down. FDA searching for new chief information officer. More personnel announcements from Endo Health Solution, STAAR Surgical and Solulink.

New Products In Brief

Japanese authority approves St. Jude’s MRI-safe pacemaker and Edwards’ Sapien XT, the first transcatheter aortic valve approved in that country. More new products.

CMS Staffs Up, Posts Resources For Upcoming Sunshine Requirements

The agency is taking steps to help companies prepare for the new physician payment disclosure mandates, which officials are now referring to as the “Open Payment Program,” while also getting ready to enforce the rules.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT032344

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel